Prostate cancer patients were significantly more likely to have stromal CD73+ cells in their than BPH patients (odds ratio = 7.2; χ2 = 21; p < .0001) (Figure 5A (a1–a3)). This evidence concerns the gene NT5E and prostate carcinoma.